about
The cost-effectiveness of the MobileMums intervention to increase physical activity among mothers with young children: a Markov model informed by a randomised controlled trial.Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events.Improved wound management at lower cost: a sensible goal for Australia.A cost-effectiveness modelling study of strategies to reduce risk of infection following primary hip replacement based on a systematic review.Ten-year patient-reported outcomes following total and minimally invasive unicompartmental knee arthroplasty: a propensity score-matched cohort analysis.Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review.A cost-effectiveness analysis of optimal care for diabetic foot ulcers in Australia.Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014.Cost-effectiveness of unicompartmental compared with total knee replacement: a population-based study using data from the National Joint Registry for England and Wales.The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study.The effect of rheumatoid arthritis on patient-reported outcomes following knee and hip replacement: evidence from routinely collected dataLifetime risk of knee and hip replacement following a diagnosis of RA: findings from a cohort of 13 961 patients from EnglandThe impact of BMI and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected dataLifetime risk of knee and hip replacement following a GP diagnosis of osteoarthritis: a real-world cohort studyModelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South AfricaKnee and hip replacements and the risk of revisionLifetime risk of knee and hip replacement following a diagnosis of RA: findings from a cohort of 13 961 patients from EnglandAn international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza
P50
Q35573083-8FEB553C-850D-49EC-B619-47631689F75EQ38380354-9F07AD4F-83F0-4301-A1A5-2B5595322415Q38658627-B727F63E-3AA5-4B23-9943-0B8B82121D42Q38911494-1CA6539A-79B9-48D8-B94A-998CE9F2BEB5Q39055374-4080F583-7396-4273-97F4-4C5617CB0A8AQ47118286-C5C7C34C-604F-4B2C-A8B6-7D71D4731A55Q48128360-0CEE6D59-23F7-4E3D-A657-29CEFDAE9972Q49644152-FEDEF888-29FF-4445-A288-79E3E6308C80Q53828055-9DEB80E7-D419-4464-A6FD-652D1AE1C0E4Q55276244-9F96DB78-B814-42E4-9294-90D75D7C03CBQ63352660-886BD735-E703-4C9B-8E3F-4C0CAC51182EQ92241612-37963D5E-38F3-49A4-A5C4-7D054CE6A150Q92463696-80769EC7-DC20-48C3-9A51-4928114F6FEAQ92907374-C38760CE-DEF1-4DAA-895E-A6E6AF8E2E2AQ93050473-D31FECFA-A247-4E92-9DF5-5A22F9E8306BQ93068503-E3B92F6E-38B1-44AA-B47F-066748DEB3ACQ94191341-C91A7FD1-3D2C-427B-87A0-EDBF254D6B80Q95601963-545C503B-4BDE-447D-9A4C-3D36B58A4F1D
P50
description
onderzoeker
@nl
researcher
@en
researcher
@en-gb
հետազոտող
@hy
name
Edward Burn
@ast
Edward Burn
@en
Edward Burn
@en-gb
Edward Burn
@es
Edward Burn
@nl
Edward Burn
@sl
type
label
Edward Burn
@ast
Edward Burn
@en
Edward Burn
@en-gb
Edward Burn
@es
Edward Burn
@nl
Edward Burn
@sl
prefLabel
Edward Burn
@ast
Edward Burn
@en
Edward Burn
@en-gb
Edward Burn
@es
Edward Burn
@nl
Edward Burn
@sl
P106
P1153
57189518535
P21
P31
P496
0000-0002-9286-1128